SBRASabra Health Care REIT, Inc.

$18.97+6.1% 1Y

What is the market doing?

Mixed

No clear lean: rangebound and insiders net selling (often routine).

3 neutral
TrendRangeboundderived · Oct 9, 2026

Rangebound, no clear trend. Oversold (RSI 25). Price is −3% vs its 200-day average.

Insider conviction−$4.2M (90 days to Oct 8, 2026)SEC EDGAR · Oct 8, 2026

Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).

Short interest8.2% of sharesFINRA · Sep 15, 2026

Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

1-year returnmiddle of the market
vs 200-day avgmiddle of the market

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How SBRA is trading

Sabra Health Care REIT, Inc. is +6.1% over the past year while the S&P 500 is +18%: 12 points behind the market.

+6.1%

1-year return · S&P 500 +18%

vs 200-day average
−3.5%

vs 200-day average · below trend, but not far

RSI (14)
25

RSI (14) · oversold, sold harder than it has been bought

Below its 52-week high
15%

Below its 52-week high

Sep 18, 2024$12.80 – $22.40 · dashed line: 200-day averageOct 9, 2026
Details›
Last close2026-10-09
$18.97
1 monthS&P 500 +2.7%
−8.9%
1 yearS&P 500 +18%
+6.1%
5 yearsS&P 500 +88%
+76%
vs 50-day average$20.29
−6.5%
52-week high
$22.40
52-week low
$16.47
Annualised volatility
24%
Calendar-year price return
YearReturn
2026 (year to date)+3.1%
2025+17%
2024+31%
2023+26%
2022+0.38%
2021−16%
2020−11%
2019+41%
2018−3.7%
2017−17%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan105 of 10+2.0%
Feb106 of 10+0.23%
Mar107 of 10−1.6%
Apr106 of 10+0.50%
May106 of 10+3.9%
Jun108 of 10+3.3%
Jul118 of 11+5.4%
Aug116 of 11+1.5%
Sep114 of 11−0.83%
Oct113 of 11−2.4%
Nov103 of 10+1.6%
Dec103 of 10−1.7%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.